ArticleCancers2020

Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival.

Chantal Bourrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.